Mebendazole inhibits growth of human adrenocortical carcinoma cell lines implanted in nude mice. (2008)

Peer-Reviewed Study · Daniele Martarelli; Pierluigi Pompei; Caterina Baldi et al. · April 2008

Daniele Martarelli et al., 2008-04: Martarelli et al. show mebendazole inhibits human adrenocortical carcinoma cells in culture and as nude-mouse implants, reducing metastases formation.

Mebendazole significantly inhibited cancer cells growth, both in vitro and in vivo, the effects being due to the induction of apoptosis.

Daniele Martarelli et al., 2008-04: Martarelli et al. show mebendazole inhibits human adrenocortical carcinoma cells in culture and as nude-mouse implants, reducing metastases formation. Study type: human adrenocortical carcinoma cell lines plus nude mouse implants. N: not stated in the abstract. Country: Italy (University of Camerino). Dose: not stated in the abstract text captured. Route/schedule: not stated in the abstract. Funder: not stated in the record. Declared conflicts: no COI statement in the record. Comparator: untreated controls. The ReDO review records this study's in vivo dosing as 1 mg and 2 mg orally every other day. Study type: animal.